Speedy Review/Approvals, R&D Support Key Items On Korea Policy Agenda This Year

But Industry Worried About Drug Price Reforms

 
• By Jung Won Shin
  
perspectives 2026
Korea and 2026
Korea Poised To Push For Regulatory Innovation, R&D Investment In 2026 (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet Perspectives

More from Pink Sheet